- Home
- KURA vs AIO Comparison
KURA vs AIO Comparison
Compare KURA & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- AIO
- Stock Information
- Founded
- KURA 2014
- AIO 2019
- Country
- KURA United States
- AIO United States
- Employees
- KURA N/A
- AIO N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- AIO Finance/Investors Services
- Sector
- KURA Health Care
- AIO Finance
- Exchange
- KURA Nasdaq
- AIO Nasdaq
- Market Cap
- KURA 713.5M
- AIO 808.3M
- IPO Year
- KURA N/A
- AIO N/A
- Fundamental
- Price
- KURA $10.14
- AIO $24.13
- Analyst Decision
- KURA Buy
- AIO
- Analyst Count
- KURA 14
- AIO 0
- Target Price
- KURA $24.45
- AIO N/A
- AVG Volume (30 Days)
- KURA 1.8M
- AIO 141.5K
- Earning Date
- KURA 11-06-2025
- AIO 01-01-0001
- Dividend Yield
- KURA N/A
- AIO 9.05%
- EPS Growth
- KURA N/A
- AIO N/A
- EPS
- KURA N/A
- AIO N/A
- Revenue
- KURA $83,279,000.00
- AIO N/A
- Revenue This Year
- KURA $68.63
- AIO N/A
- Revenue Next Year
- KURA $141.59
- AIO N/A
- P/E Ratio
- KURA N/A
- AIO N/A
- Revenue Growth
- KURA N/A
- AIO N/A
- 52 Week Low
- KURA $5.41
- AIO $15.09
- 52 Week High
- KURA $19.73
- AIO $20.25
- Technical
- Relative Strength Index (RSI)
- KURA 69.23
- AIO 40.90
- Support Level
- KURA $9.48
- AIO $23.76
- Resistance Level
- KURA $9.96
- AIO $24.38
- Average True Range (ATR)
- KURA 0.41
- AIO 0.38
- MACD
- KURA 0.06
- AIO -0.02
- Stochastic Oscillator
- KURA 81.78
- AIO 10.31
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.